Gw Pharmaceuticals Plc's ability to collect accounts receivable sequentially worsen to 7.06, indicating more challenging environment then in the fourth quarter 2020, but still, it is a far cry from any concerns. Gw Pharmaceuticals Plc's Accounts Receivable average collection period in the Mar 31 2021 quarter, has increased to 52 days, from 51 days, in the Dec 31 2020 quarter.

If we take a look into Healthcare sector 291 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2253, from overall ranking in the fourth quarter 2020 at 2986.

What is Receivable Turnover Ratio?
What is Gw Pharmaceuticals Plc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GWPH Receivables Turnover Ratio	(Mar 31 2021) I. Quarter	(Dec 31 2020) IV. Quarter	(Sep 30 2020) III. Quarter	(Jun 30 2020) II. Quarter	(Mar 31 2020) I. Quarter
Y / Y Receivable Change	36.55 %	45.59 %	92.32 %	150.23 %	223.15 %
Y / Y Revenue Change	26.39 %	35.89 %	50.66 %	68.38 %	207.37 %
Receivable Turnover Ratio (TTM)	7.06	7.17	7.18	7.58	8.49
GWPH's Total Ranking	# 2253	# 2986	# 2985	# 2985	# 2985
Accounts Receivable average collection period days	52	51	51	48	43
Seq. Receivable Change	19.36 %	-11.51 %	0.08 %	29.17 %	27.26 %
Seq. Revenue Change	2.86 %	8.15 %	12.99 %	0.55 %	10.6 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 79
Healthcare Sector	# 292
Overall Market	# 2253

Receivable Turnover Ratio Statistics
High	Average	Low
0.56	0.44	0.35
(Sep 30 2020)		(Dec 31 2020)

GWPH Company Profile • Back to GWPH Efficiency Comparisons • Compare GWPH Receivables Turnover Ratio to its Competitors

Financial Statements
Gw Pharmaceuticals Plc's Accounts Receivable	$ 85 Millions	Visit GWPH's Balance sheet
Gw Pharmaceuticals Plc's Sales TTM	$ 559 Millions	Visit GWPH's Income Statement
Sources of GWPH's Revenues		Visit GWPH's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GWPH's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
GWPH's Growth Rates	GWPH's Roa	GWPH's Inventory Turnover Ratio	GWPH's Dividend Comparisons
GWPH's Profitability Ratios	GWPH's Roi	GWPH's Asset Turnover Ratio	GWPH's Dividend Growth
GWPH's Valuation Ratios	GWPH's Roe	GWPH's Financial Strength Ratios	GWPH's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2021, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2021	Receivable at quarter ending Mar 31 2021
Rafael Holdings Inc	17.90	$ 4.242 Millions	$ 0.237 Millions
Chemed Corporation	17.61	$ 2,091.145 Millions	$ 118.732 Millions
Mannkind Corporation	17.35	$ 66.345 Millions	$ 3.823 Millions
Inhibikase Therapeutics Inc	16.91	$ 1.407 Millions	$ 0.083 Millions
Neurometrix Inc	15.89	$ 7.361 Millions	$ 0.463 Millions
Agenus Inc	15.86	$ 84.761 Millions	$ 5.343 Millions
Cormedix Inc	15.81	$ 0.253 Millions	$ 0.016 Millions
Merus N v	15.79	$ 31.992 Millions	$ 2.026 Millions
Skinvisible Inc	15.76	$ 0.156 Millions	$ 0.010 Millions
Histogen Inc	15.59	$ 2.490 Millions	$ 0.160 Millions
Myomo Inc	15.44	$ 8.912 Millions	$ 0.577 Millions
La Jolla Pharmaceutical Company	15.22	$ 59.965 Millions	$ 3.940 Millions
Emmaus Life Sciences Inc	14.98	$ 21.548 Millions	$ 1.438 Millions
One World Products Inc	14.97	$ 0.083 Millions	$ 0.006 Millions
Ultragenyx Pharmaceutical Inc	14.72	$ 334.116 Millions	$ 22.695 Millions
Arrowhead Pharmaceuticals Inc	14.65	$ 89.123 Millions	$ 6.085 Millions
Corcept Therapeutics Inc	14.61	$ 340.064 Millions	$ 23.270 Millions
Semler Scientific inc	14.55	$ 42.356 Millions	$ 2.911 Millions
Cytokinetics Incorporated	14.50	$ 58.551 Millions	$ 4.038 Millions
Ibio inc	14.32	$ 3.000 Millions	$ 0.210 Millions
Chimerix Inc	14.21	$ 5.566 Millions	$ 0.392 Millions
Protalix Biotherapeutics inc	14.01	$ 52.572 Millions	$ 3.752 Millions
Dmk Pharmaceuticals Corporation	13.99	$ 15.973 Millions	$ 1.142 Millions
Apria inc	13.98	$ 275.274 Millions	$ 19.691 Millions
Nutriband Inc	13.77	$ 1.258 Millions	$ 0.091 Millions
Therapeutic Solutions International Inc	13.71	$ 0.064 Millions	$ 0.005 Millions
Rockwell Medical inc	13.39	$ 61.813 Millions	$ 4.616 Millions
Patterson Companies Inc	13.37	$ 5,912.066 Millions	$ 442.344 Millions
Sunlink Health Systems Inc	13.20	$ 55.844 Millions	$ 4.231 Millions
Lensar Inc	13.15	$ 27.519 Millions	$ 2.093 Millions

Date modified: 2026-08-30T19:20:09+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.